Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Smim24em1flox/Cya
Common Name:
Smim24-flox
Product ID:
S-CKO-15414
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Smim24-flox
Strain ID
CKOCMP-72273-Smim24-B6J-VA
Gene Name
Smim24
Product ID
S-CKO-15414
Gene Alias
2210404O07Rik
Background
C57BL/6JCya
NCBI ID
72273
Modification
Conditional knockout
Chromosome
10
Phenotype
MGI:1919523
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Smim24em1flox/Cya mice (Catalog S-CKO-15414) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000105322
NCBI RefSeq
NM_001099917
Target Region
Exon 1~3
Size of Effective Region
~1.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Smim24, whose full name is Small Integral Membrane Protein 24, is a gene with its function yet to be fully elucidated. However, its involvement in multiple biological contexts has been noted. It may be associated with various cellular processes considering its appearance in different tissue-related transcriptomic studies [3,4].

Smim24 has been identified in multiple prognostic models. In clear-cell renal-cell carcinoma (ccRCC), it is part of a prognostic model related to activated dendritic cells, and the model can predict outcomes in advanced ccRCC patients, and is associated with tumor progression, tumor mutation burden, immune cell infiltration, and immunotherapy outcomes [1]. It is also part of a prognostic model in ccRCC related to chemokine-related genes, where high-risk group patients with higher expression of Smim24 and other genes have a poorer prognosis [2]. Additionally, in a study on clear cell renal carcinoma, Smim24 was screened to construct a risk model for predicting prognosis and drug sensitivity [7].

In a transcriptomic analysis of human α-cells, the expression of Smim24 was altered in α-pseudoislets in a time-dependent manner [3]. In a hepatocellular carcinoma cell line Li-7, Smim24 was among the genes overexpressed in cancer stem cell-like CD13+CD166-cells which maintain tumorigenicity [4]. In a study on longitudinal gene expression changes in cognitively intact older adults, Smim24 was among the genes showing differential expression in APOE4 carriers, potentially implicating disrupted immune system, protein removal, and metabolism [5]. In a case of 19p13.3 microduplication syndrome, Smim24 was within a duplicated region in a patient with nephrotic syndrome and other clinical phenotypes [6].

In conclusion, Smim24 seems to be involved in the prognosis and biological processes related to multiple diseases, especially in renal-related carcinomas. Its appearance in various prognostic models and differential expression in disease-related cell types or genetic conditions suggest its importance in understanding disease mechanisms, which may provide new insights for disease treatment and prediction [1,2,3,4,5,6,7].

References:
1. Ye, Zijian, Zhang, Yifan, Xu, Jialiang, Wang, Meijiao, Xie, Biao. 2024. Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma. In International journal of molecular sciences, 25, . doi:10.3390/ijms25179235. https://pubmed.ncbi.nlm.nih.gov/39273185/
2. Meng, Yuhao, Zhang, Chen, Fu, Tongfei, Wu, Junsong, Zhan, Yongli. 2024. RETRACTED: Exploring the tumor microenvironment: Chemokine-related genes and immunotherapy/chemotherapy response in clear-cell renal cell carcinoma. In Environmental toxicology, 40, E74-E91. doi:10.1002/tox.24190. https://pubmed.ncbi.nlm.nih.gov/38488671/
3. Kahraman, Sevim, Shibue, Kimitaka, De Jesus, Dario F, Choudhary, Amit, Kulkarni, Rohit N. 2023. Fluorescein-based sensors to purify human α-cells for functional and transcriptomic analyses. In eLife, 12, . doi:10.7554/eLife.85056. https://pubmed.ncbi.nlm.nih.gov/37732504/
4. Seyama, Yusuke, Sudo, Kazuhiro, Hirose, Suguru, Tsuchiya, Kiichiro, Nakamura, Yukio. 2023. Identification of a gene set that maintains tumorigenicity of the hepatocellular carcinoma cell line Li-7. In Human cell, 36, 2074-2086. doi:10.1007/s13577-023-00967-7. https://pubmed.ncbi.nlm.nih.gov/37610679/
5. Luckett, Emma S, Zielonka, Magdalena, Kordjani, Amine, Cleynen, Isabelle, Vandenberghe, Rik. 2023. Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults. In Alzheimer's research & therapy, 15, 121. doi:10.1186/s13195-023-01242-5. https://pubmed.ncbi.nlm.nih.gov/37438770/
6. Sun, Wenjie, Yan, Hong, Sun, Mengxin, Wang, Jie, Li, Kunxia. 2025. Expanding the clinical spectrum of 19p13.3 microduplication syndrome: a case report highlighting nephrotic syndrome and literature review. In BMC pediatrics, 25, 70. doi:10.1186/s12887-025-05394-1. https://pubmed.ncbi.nlm.nih.gov/39875952/
7. Chang, Qinzheng, Zhao, Shuo, Sun, Jiajia, Fan, Yidong, Liu, Jikai. 2025. Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes. In Frontiers in endocrinology, 16, 1521940. doi:10.3389/fendo.2025.1521940. https://pubmed.ncbi.nlm.nih.gov/40099255/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest